These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 32619652)

  • 1. Design and development of 1,3,5-triazine-thiadiazole hybrids as potent adenosine A
    Masih A; Singh S; Agnihotri AK; Giri S; Shrivastava JK; Pandey N; Bhat HR; Singh UP
    Neurosci Lett; 2020 Sep; 735():135222. PubMed ID: 32619652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of novel 1,3,5-triazine as adenosine A
    Masih A; Agnihotri AK; Srivastava JK; Pandey N; Bhat HR; Singh UP
    J Biochem Mol Toxicol; 2021 Mar; 35(3):e22659. PubMed ID: 33156955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure of the adenosine A
    Sun B; Bachhawat P; Chu ML; Wood M; Ceska T; Sands ZA; Mercier J; Lebon F; Kobilka TS; Kobilka BK
    Proc Natl Acad Sci U S A; 2017 Feb; 114(8):2066-2071. PubMed ID: 28167788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of potent adenosine A2a antagonists as potential anti-Parkinson disease agents. Non-linear QSAR analyses integrated with pharmacophore modeling.
    Khanfar MA; Al-Qtaishat S; Habash M; Taha MO
    Chem Biol Interact; 2016 Jul; 254():93-101. PubMed ID: 27216633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of Adenosine A
    Zheng J; Zhang X; Zhen X
    ACS Chem Neurosci; 2019 Feb; 10(2):783-791. PubMed ID: 30199223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of nonxanthine adenosine A2A receptor antagonists for the treatment of Parkinson's disease.
    Weiss SM; Benwell K; Cliffe IA; Gillespie RJ; Knight AR; Lerpiniere J; Misra A; Pratt RM; Revell D; Upton R; Dourish CT
    Neurology; 2003 Dec; 61(11 Suppl 6):S101-6. PubMed ID: 14663021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occupancy of adenosine A
    Ishibashi K; Miura Y; Wagatsuma K; Toyohara J; Ishiwata K; Ishii K
    Neuropharmacology; 2018 Dec; 143():106-112. PubMed ID: 30253174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, biological evaluation and molecular modelling studies of 1,3,7,8-tetrasubstituted xanthines as potent and selective A
    Rohilla S; Bansal R; Kachler S; Klotz KN
    Bioorg Chem; 2019 Jun; 87():601-612. PubMed ID: 30933785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel approaches for targeting the adenosine A2A receptor.
    Yuan G; Gedeon NG; Jankins TC; Jones GB
    Expert Opin Drug Discov; 2015 Jan; 10(1):63-80. PubMed ID: 25311639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of indolylpiperazinylpyrimidines with dual-target profiles at adenosine A2A and dopamine D2 receptors for Parkinson's disease treatment.
    Shao YM; Ma X; Paira P; Tan A; Herr DR; Lim KL; Ng CH; Venkatesan G; Klotz KN; Federico S; Spalluto G; Cheong SL; Chen YZ; Pastorin G
    PLoS One; 2018; 13(1):e0188212. PubMed ID: 29304113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of 1,2,4-triazine derivatives as adenosine A(2A) antagonists using structure based drug design.
    Congreve M; Andrews SP; Doré AS; Hollenstein K; Hurrell E; Langmead CJ; Mason JS; Ng IW; Tehan B; Zhukov A; Weir M; Marshall FH
    J Med Chem; 2012 Mar; 55(5):1898-903. PubMed ID: 22220592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosine A
    Hagenow S; Affini A; Pioli EY; Hinz S; Zhao Y; Porras G; Namasivayam V; Müller CE; Lin JS; Bezard E; Stark H
    J Med Chem; 2021 Jun; 64(12):8246-8262. PubMed ID: 34107215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. JNJ-40255293, a novel adenosine A2A/A1 antagonist with efficacy in preclinical models of Parkinson's disease.
    Atack JR; Shook BC; Rassnick S; Jackson PF; Rhodes K; Drinkenburg WH; Ahnaou A; Te Riele P; Langlois X; Hrupka B; De Haes P; Hendrickx H; Aerts N; Hens K; Wellens A; Vermeire J; Megens AA
    ACS Chem Neurosci; 2014 Oct; 5(10):1005-19. PubMed ID: 25203719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Basis of Ligand Dissociation from the Adenosine A2A Receptor.
    Guo D; Pan AC; Dror RO; Mocking T; Liu R; Heitman LH; Shaw DE; IJzerman AP
    Mol Pharmacol; 2016 May; 89(5):485-91. PubMed ID: 26873858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of (4E)-4-(4-substitutedbenzylideneamino)-3-substituted-2,3-dihydro-2-thioxothiazole-5-carbonitrile as novel A2A receptor antagonists.
    Mishra CB; Sharma D; Prakash A; Kumari N; Kumar N; Luthra PM
    Bioorg Med Chem; 2013 Oct; 21(19):6077-83. PubMed ID: 23953686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Piperazine derivatives of [1,2,4]triazolo[1,5-a][1,3,5]triazine as potent and selective adenosine A2a receptor antagonists.
    Vu CB; Peng B; Kumaravel G; Smits G; Jin X; Phadke D; Engber T; Huang C; Reilly J; Tam S; Grant D; Hetu G; Chen L; Zhang J; Petter RC
    J Med Chem; 2004 Aug; 47(17):4291-9. PubMed ID: 15294001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel adenosine A(2A) receptor ligands: a synthetic, functional and computational investigation of selected literature adenosine A(2A) receptor antagonists for extending into extracellular space.
    Jörg M; Shonberg J; Mak FS; Miller ND; Yuriev E; Scammells PJ; Capuano B
    Bioorg Med Chem Lett; 2013 Jun; 23(11):3427-33. PubMed ID: 23602401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2-Benzylidene-1-Indanone Analogues as Dual Adenosine A1/A2a Receptor Antagonists for the Potential Treatment of Neurological Conditions.
    van Rensburg HJ; Legoabe L; Terre'Blanche G; Van der Walt M
    Drug Res (Stuttg); 2019 Jul; 69(7):382-391. PubMed ID: 30616250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the adenosine A
    Zhao Y; Zhou YG; Chen JF
    Chin J Traumatol; 2024 May; 27(3):125-133. PubMed ID: 37679245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Docking Screens for Dual Inhibitors of Disparate Drug Targets for Parkinson's Disease.
    Jaiteh M; Zeifman A; Saarinen M; Svenningsson P; Bréa J; Loza MI; Carlsson J
    J Med Chem; 2018 Jun; 61(12):5269-5278. PubMed ID: 29792714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.